EUCTR2009-017295-24-CZ进行中（未招募）不适用
Phase I/II clinical trial:Immunotherapy of hormone-refractory prostate cancer patients with dendritic cell-based vaccine (Fáze I/II klinické studie imunoterapie hormonálne refrakterního karcinomu prostaty pomocí vakcinace dendritickými bunkami) - Imunoterapie karcinomu prostaty dendritickými bunkami
niversity Hospital Motol0 个研究点开始时间: 2009年12月14日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Histological confirmed prostatic adenocarcinoma
- •Progression of PSA serum concentration after the failure of second line hormonal therapy in generalized disease
- •Karnofsky performance status more than 80%
- •Signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •HIV positivity, active B or C hepatitis
- •Severe cardiac or other internal disease limiting patient survival
- •History of primary immunodeficiency, active autoimmunity requiring tratment or anaphylactic reaction after previous vaccination
- •Negative informed consent
研究者
相似试验
已完成
不适用
Clinical trial of immunomodulatory therapy using anti-thymocyte globulin and pegfilgrastim for recently onset type 1 diabetesType 1 diabetesJPRN-UMIN000027070Toyama University12
进行中（未招募）
不适用
Phase I/II clinical trial: Immunotherapy of prostate cancer patients in biochemical relapse with dendritic cell-based vaccine - Imunoterapie karcinomu prostaty dendritickými bunkamiPatients with prostate cancer in the stage of biochemical relapseEUCTR2009-017259-91-CZniversity Hospital Motol
进行中（未招募）
2 期
A CLINICAL TRIAL TO STUDY THE EFFICACY AND SAFETY OF PT 107 (VACCINE) IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTSCTRI/2010/091/001348PIQUE THERAPEUTICS INC100
进行中（未招募）
1 期
Clinical evaluation of virus therapy for cancerColorectal, ovarian, pancreatic, gallbladder and bile duct cancerMedDRA version: 20.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 100000004864EUCTR2017-002565-22-SEokon Pharma AB80
已完成
不适用
Phase II clinical trial of immunotherapy with WT1 peptide vaccination for pediatric hematological malignancies after allogeneic stem cell transplantation.Acute lymphoid or myeloid leukemia, acute unclassified leukemia, malignant lymphomaJPRN-UMIN000005319Osaka University22